Dirk Kosemund
-
- Microtubule and mitosis dynamics 1
-
- Cancer-related Molecular Pathways 2
- HER2/EGFR in Cancer Research 1
- Peptidase Inhibition and Analysis 1
-
- Ubiquitin and proteasome pathways 1
- Protein Degradation and Inhibitors 1
- 14-3-3 protein interactions 1
- PI3K/AKT/mTOR signaling in cancer 1
Dirk Kosemund
3 papers receiving 158 citations
Peers
Comparison fields: 5 of 29
- Cell Biology 51
- Oncology 80
- Molecular Biology 107
- Genetics 16
- Organic Chemistry 29
Countries citing papers authored by Dirk Kosemund
This map shows the geographic impact of Dirk Kosemund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Kosemund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Kosemund more than expected).
Fields of papers citing papers by Dirk Kosemund
This network shows the impact of papers produced by Dirk Kosemund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Kosemund. The network helps show where Dirk Kosemund may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dirk Kosemund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 53 | |
| 2 | 2017 | 26 | |
| 3 | 2016 | 85 |
About Dirk Kosemund
Dirk Kosemund is a scholar working on Oncology, Cell Biology and Molecular Biology, having authored 3 papers that have together received 164 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (2 papers), HER2/EGFR in Cancer Research (1 paper), Microtubule and mitosis dynamics (1 paper), Peptidase Inhibition and Analysis (1 paper), Ubiquitin and proteasome pathways (1 paper), Protein Degradation and Inhibitors (1 paper), 14-3-3 protein interactions (1 paper) and PI3K/AKT/mTOR signaling in cancer (1 paper). The work is most often cited by research in Cell Biology (51 citations), Oncology (80 citations) and Molecular Biology (107 citations). Dirk Kosemund has collaborated with scholars based in Germany and United Kingdom. Frequent co-authors include Gerhard Siemeister, Franz von Nussbaum, Dominik Mumberg, Philip Lienau, Michael Brands, Karl Ziegelbauer, Hans Briem, Arne Scholz, Stuart Ince and Rolf Bohlmann. Their work appears in journals such as Cancer Research, Journal of Medicinal Chemistry and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.